1. Market Research
  2. > Postoperative Ileus - Pipeline Review, H1 2013

Postoperative Ileus - Pipeline Review, H1 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 32 pages

Postoperative Ileus - Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Postoperative Ileus - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Postoperative Ileus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Postoperative Ileus. Postoperative Ileus - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope


- A snapshot of the global therapeutic scenario for Postoperative Ileus.
- A review of the Postoperative Ileus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Postoperative Ileus pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.


Reasons to buy


- Identify and understand important and diverse types of therapeutics under development for Postoperative Ileus.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Postoperative Ileus pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

Postoperative Ileus - Pipeline Review, H1 2013
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Postoperative Ileus Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Postoperative Ileus 7
Postoperative Ileus Therapeutics under Development by Companies 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Discovery and Pre-Clinical Stage Products 11
Comparative Analysis 11
Postoperative Ileus Therapeutics - Products under Development by Companies 12
Companies Involved in Postoperative Ileus Therapeutics Development 13
LG Life Sciences, Ltd 13
Helsinn Healthcare S.A. 14
Botanic Century 15
RaQualia Pharma Inc. 16
Postoperative Ileus - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
RQ-00201894 - Drug Profile 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Melokinex - Drug Profile 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
ipamorelin - Drug Profile 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
LD02GIFRO - Drug Profile 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
Drug For Bowel Motility Disorders - Drug Profile 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Postoperative Ileus Therapeutics - Drug Profile Updates 27
Postoperative Ileus Therapeutics - Discontinued Products 28
Postoperative Ileus Therapeutics - Dormant Products 29
Postoperative Ileus - Product Development Milestones 30
Featured News and Press Releases 30
Sep 14, 2012: RaQualia Pharma's Motilin Receptor Agonist RQ-00201894 Advances To Pre-clinical Stage 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables


Number of Products Under Development for Postoperative Ileus, H1 2013 7
Products under Development for Postoperative Ileus - Comparative Analysis, H1 2013 8
Number of Products under Development by Companies, H1 2013 9
Comparative Analysis by Mid Clinical Stage Development, H1 2013 10
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013 11
Products under Development by Companies, H1 2013 12
LG Life Sciences, Ltd, H1 2013 13
Helsinn Healthcare S.A., H1 2013 14
Botanic Century, H1 2013 15
RaQualia Pharma Inc., H1 2013 16
Assessment by Monotherapy Products, H1 2013 17
Assessment by Stage and Route of Administration, H1 2013 19
Assessment by Stage and Molecule Type, H1 2013 21
Postoperative Ileus Therapeutics - Drug Profile Updates 27
Postoperative Ileus Therapeutics - Discontinued Products 28
Postoperative Ileus Therapeutics - Dormant Products 29

List of Figures


Number of Products under Development for Postoperative Ileus, H1 2013 7
Products under Development for Postoperative Ileus - Comparative Analysis, H1 2013 8
Products under Development by Companies, H1 2013 9
Mid Clinical Stage Products, H1 2013 10
Discovery and Pre-Clinical Stage Products, H1 2013 11
Assessment by Monotherapy Products, H1 2013 17
Assessment by Route of Administration, H1 2013 18
Assessment by Stage and Route of Administration, H1 2013 19
Assessment by Molecule Type, H1 2013 20
Assessment by Stage and Molecule Type, H1 2013 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.